All sponsors

Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-30
RECRUITING5
READOUTS ≤12 MONTHS2
Open Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
HL-1186
NCT07147049
P2RecruitingModerate to Severe Acute Postoperative Pain722025-12
HL-1186
NCT07311369
P2RecruitingModerate to Severe Acute Postoperative Pain402026-02
HTMC0658
NCT07174115
P2RecruitingChronic Sinusitis Without Nasal Polyps302026-04
HL-1186
NCT07159243
P2Not yet recruitingDiabetic Peripheral Neuropathic Pain1802026-10
YD0743
NCT07413094
P2RecruitingSepsis3092026-12
HL-1186
NCT07758920
P2RecruitingPostherpetic Neuralgia ( PHN )2002027-06